Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Halozyme Therapeutics Incorporated | HALO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 49.62 | 04:00:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 49.62 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 32.78 - 53.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 49.62 | USD |
Halozyme Therapeutics Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.29B | 126.82M | - | 829.25M | 281.59M | 2.22 | 22.35 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Halozyme Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HALO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 51.40 | 51.66 | 48.86 | 50.35 | 1,657,580 | -1.78 | -3.46% |
| 1 Month | 45.36 | 53.00 | 42.05 | 47.59 | 1,332,738 | 4.26 | 9.39% |
| 3 Months | 40.30 | 53.00 | 37.73 | 43.50 | 1,060,529 | 9.32 | 23.13% |
| 6 Months | 42.62 | 53.00 | 33.15 | 39.60 | 1,235,856 | 7.00 | 16.42% |
| 1 Year | 34.02 | 53.00 | 32.78 | 39.32 | 1,101,056 | 15.60 | 45.86% |
| 3 Years | 43.56 | 59.46 | 29.85 | 41.29 | 1,109,503 | 6.06 | 13.91% |
| 5 Years | 15.83 | 59.46 | 12.71 | 35.43 | 1,205,149 | 33.79 | 213.46% |
Halozyme Therapeutics Description
| Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. |
